The potential of methylxanthine-based therapies in pediatric respiratory tract diseases.
Respir Med. 2016 Mar;112:1-9. doi: 10.1016/j.rmed.2016.01.022. Epub 2016 Feb 1.
Respir Med. 2016.
PMID: 26880379
Review.